Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$864M |
| 2 |
T-Mobile US
TMUS
|
+$580M |
| 3 |
Meta Platforms (Facebook)
META
|
+$367M |
| 4 |
AbbVie
ABBV
|
+$348M |
| 5 |
Blackrock
BLK
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$692M |
| 2 |
RTN
Raytheon Company
RTN
|
+$368M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$279M |
| 4 |
Visa
V
|
+$237M |
| 5 |
Intel
INTC
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.84% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 13.35% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Adecoagro
AGRO
$1.44B
| $2.93M | ﹤0.01% |
675,635
-511,508
| -43% | -$2.14M |
|
1927
Kamada
KMDA
$412M
| $2.92M | ﹤0.01% |
381,963
| – | – |
|
|
UBA
1928
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $2.92M | ﹤0.01% |
245,805
-179,285
| -42% | -$2.31M |
|
1929
SM Energy
SM
$7.8B
| $2.92M | ﹤0.01% |
777,691
-514,169
| -40% | -$1.68M |
|
1930
Fate Therapeutics
FATE
$286M
| $2.88M | ﹤0.01% |
+83,900
| New | +$2.5M |
|
1931
Clearwater Paper
CLW
$339M
| $2.8M | ﹤0.01% |
77,607
-30,321
| -28% | -$843K |
|
1932
Donnelley Financial Solutions
DFIN
$1.16B
| $2.8M | ﹤0.01% |
333,348
| – | – |
|
1933
E.W. Scripps
SSP
$257M
| $2.72M | ﹤0.01% |
311,060
| – | – |
|
|
RUBY
1934
DELISTED
Rubius Therapeutics, Inc
RUBY
| $2.69M | ﹤0.01% |
450,000
| – | – |
|
1935
TFS Financial
TFSL
$5.16B
| $2.69M | ﹤0.01% |
187,742
+157,980
| +531% | +$2.28M |
|
1936
Vroom Inc
VRM
$39M
| $2.61M | ﹤0.01% |
+625
| New | +$2.42M |
|
1937
Standard BioTools
LAB
$340M
| $2.59M | ﹤0.01% |
646,628
| – | – |
|
1938
BioCryst Pharmaceuticals
BCRX
$2.28B
| $2.59M | ﹤0.01% |
+543,493
| New | +$2.17M |
|
1939
Levi Strauss
LEVI
$9.44B
| $2.58M | ﹤0.01% |
192,176
| – | – |
|
|
MTSC
1940
DELISTED
MTS Systems Corp
MTSC
| $2.56M | ﹤0.01% |
145,820
-75,338
| -34% | -$1.39M |
|
|
PFNX
1941
DELISTED
Pfenex Inc.
PFNX
| $2.55M | ﹤0.01% |
305,910
| – | – |
|
1942
Central Garden & Pet Co
CENT
$2.69B
| $2.52M | ﹤0.01% |
+87,380
| New | +$2.35M |
|
|
QTT
1943
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
| $2.48M | ﹤0.01% |
83,258
+38,314
| +85% | +$1M |
|
|
AZUL
1944
DELISTED
Azul
AZUL
| $2.46M | ﹤0.01% |
220,189
| – | – |
|
1945
Arvinas
ARVN
$518M
| $2.45M | ﹤0.01% |
+73,000
| New | +$3.1M |
|
|
CBAY
1946
DELISTED
Cymabay Therapeutics
CBAY
| $2.4M | ﹤0.01% |
+688,825
| New | +$1.99M |
|
|
TMUSR
1947
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
| $2.38M | ﹤0.01% |
+14,147,017
| New | +$3.97M |
|
1948
Hudbay
HBM
$10.1B
| $2.31M | ﹤0.01% |
762,703
-781,400
| -51% | -$1.96M |
|
|
QEP
1949
DELISTED
QEP RESOURCES, INC.
QEP
| $2.31M | ﹤0.01% |
1,789,606
-1,013,581
| -36% | -$946K |
|
1950
Axogen
AXGN
$2.27B
| $2.25M | ﹤0.01% |
243,501
+64,969
| +36% | +$582K |
|
Similar funds
Norges Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Norges Bank held 2,120 positions worth $347B, up 24% from $281B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Norges Bank's Q2 2020 filing shows 74 new, 993 increased, 738 reduced and 44 closed positions. Its largest new stake was Nikola Corporation Common Stock: 333,333 shares worth $675M. The largest sale was Allergan plc, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Norges Bank's largest Q2 2020 buy was Nikola Corporation Common Stock: 333,333 shares worth $675M.
- Norges Bank added most to Walmart Inc in Q2 2020, an estimated $864M increase.
- Norges Bank's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $279M.
- Norges Bank fully exited Allergan plc in Q2 2020, selling an estimated $692M.
- Norges Bank's ten largest holdings make up 22% of its $347B portfolio in Q2 2020.
- Norges Bank opened 74 new positions and closed 44 in Q2 2020.
- Norges Bank's portfolio value rose 24% quarter-over-quarter to $347B.
Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.